Schedule of maturity of financial liabilities |
Schedule of maturity of
financial liabilities
December 31, 2022 | |
Carrying amounts | | |
Total | | |
2 months or less | | |
2-12 months | | |
12-24 months | | |
More than 2 years | |
December 31, 2022 | |
Carrying amounts | | |
Total | | |
2 months or less | | |
2-12 months | | |
12-24 months | | |
More than 2 years | |
Financial liabilities | |
£ | | |
£ | | |
£ | | |
£ | | |
£ | | |
£ | |
Trade payables | |
| 882,364 | | |
| 882,364 | | |
| 882,364 | | |
| - | | |
| - | | |
| - | |
Convertible loan | |
| 655,923 | | |
| 655,923 | | |
| 655,923 | | |
| - | | |
| - | | |
| - | |
Other payables | |
| 1,276,694 | | |
| 1,276,694 | | |
| 705,976 | | |
| 570,718 | | |
| - | | |
| - | |
Financial liabilities | |
| 2,814,981 | | |
| 2,814,981 | | |
| 2,244,263 | | |
| 570,718 | | |
| - | | |
| - | |
December 31, 2021 | |
Carrying amounts | | |
Total | | |
2 months or less | | |
2-12 months | | |
12-24 months | | |
More than 2 years | |
Financial liabilities | |
£ | | |
£ | | |
£ | | |
£ | | |
£ | | |
£ | |
Trade payables | |
| 1,422,393 | | |
| 1,422,393 | | |
| 1,422,393 | | |
| - | | |
| - | | |
| - | |
Convertible loan | |
| 13,731,864 | | |
| 20,359,893 | | |
| 10,088,496 | | |
| 10,271,397 | | |
| | | |
| | |
Other payables | |
| 2,681,223 | | |
| 2,681,223 | | |
| 831,029 | | |
| 1,850,194 | | |
| - | | |
| - | |
Financial liabilities | |
| 17,835,480 | | |
| 24,463,509 | | |
| 12,341,918 | | |
| 12,121,591 | | |
| - | | |
| - | |
|
Schedule of lease liabilities |
Schedule
of lease liabilities
| |
January 1, 2022 | | |
Cash flows | | |
New leases | | |
Other | | |
December 31, 2022 | |
| |
£ | | |
£ | | |
£ | | |
£ | | |
£ | |
Current lease liabilities | |
| 765,758 | | |
| (762,150 | ) | |
| - | | |
| 324,425 | | |
| 328,033 | |
Convertible loan notes | |
| 13,731,864 | | |
| (2,632,324 | ) | |
| - | | |
| (10,443,617 | ) | |
| 655,923 | |
Non-current lease liabilities | |
| 2,136,875 | | |
| - | | |
| - | | |
| (324,425 | ) | |
| 1,812,450 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| 16,634,497 | | |
| (3,394,474 | ) | |
| - | | |
| (10,443,617 | ) | |
| 2,796,406 | |
TC
BIOPHARM (HOLDINGS) PLC
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
24. Risk management (continued)
| |
January 1, 2021 | | |
Cash flows | | |
New leases | | |
Other | | |
December 31, 2021 | |
| |
£ | | |
£ | | |
£ | | |
£ | | |
£ | |
Current lease liabilities | |
| 442,702 | | |
| (122,469 | ) | |
| - | | |
| 445,525 | | |
| 765,758 | |
Convertible loan notes | |
| - | | |
| 6,383,659 | | |
| - | | |
| 7,348,205 | | |
| 13,731,864 | |
Non-current lease liabilities | |
| 2,582,400 | | |
| - | | |
| - | | |
| (445,525 | ) | |
| 2,136,875 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| 3,025,102 | | |
| 6,261,190 | | |
| - | | |
| 7,348,205 | | |
| 16,634,497 | |
|